Covidien announced a voluntary recall of certain lots of Monoject prefill flush syringes. This recall is following the risk that a number of the syringes were filled with water but not subjected to ...
IV Flush Syringe Market Size [2022] | to extend USD 428.0 million by 2028, exhibiting a CAGR of 5.7%
Rising chronic disorders is expected to boost the demand for IV flush syringe. As per the data provided by the Healthcare Cost & Utilization Project, in the U.S., arthritis, cardiac diseases, COPD, ...
WASHINGTON, Aug. 20 (UPI) -- Covidien, a healthcare products producer, initiated a voluntary recall of certain lots of Monoject prefill flush syringes, U.S. government officials say. The U.S. Food and ...
Nurse Assist Inc. announced a recall of 386,175 Normal Saline Flush IV Syringes due to possible Burkholderia Cepacia contamination. Nurse Assist Inc. announced a recall of 386,175 Normal Saline Flush ...
The FDA on March 21 shared recommendations for healthcare organizations to conserve prefilled 0.9 percent sodium chloride intravenous lock/flush syringes amid a national shortage. 1. Use ...
October 18, 2010 — Certain syringes manufactured by Excelsior Medical are subject to a class 1 recall because of a potential loss of sterility, the US Food and Drug Administration (FDA) announced ...
BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...
FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million ...
(Reuters) – Medical device maker Covidien Plc said it was recalling 14 lots of its Monoject prefill flush syringes sold in the United States and Bermuda as they contained non-sterilized water which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results